Original Research
Published on 31 May 2021
Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses
in B Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2021.662909
- 5,589 views
- 6 citations
